article thumbnail

3 Stocks to Buy Today as Investment Banking Rebounds

The Motley Fool

After a two-year slump, investment banking looks like it's entering the early stages of a recovery. Investment banks reported earnings growth of double-digit percentages in the first quarter, driven by strong initial public offering ( IPO ) markets and a pick-up in debt underwriting. It wasn't entirely by choice.

article thumbnail

Reddit Is Exploring a 2024 IPO. Could This Be Good News for Investment Banks?

The Motley Fool

Investment banks also eagerly await the IPO and are hopeful that it can set the stage for a rebound in 2024. Here's what you need to know about the potential investing opportunity. According to data from Dealogic, companies raised nearly $154 billion through IPOs in 2021. Image source: Getty Images. Chart by author.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reddit Is Going Public Soon. Here's Why That Could Be Good News for Investment Banks.

The Motley Fool

It'll also be an important barometer for investment banks and could signal an intriguing investing opportunity. After a record year in 2021, when 951 companies went public through IPO, the past two years saw 175 total. Investment banks could get a big boost Investment bankers hope 2024 will be a bounce-back year for IPOs.

article thumbnail

Branford’s Lafayette Instrument Adds-On with Buy of Alzet Osmotic Pumps

Private Equity Professional

The Alzet acquisition marks Lafayette’s third add-on acquisition since its purchase by Branford Castle in April 2021. Aquilo Partners , a life sciences-focused investment bank with offices in San Francisco, Boston, and New York City, served as the financial advisor to DURECT Corporation.

Debt 130
article thumbnail

Liftoff eyes $4bn valuation as Blackstone weighs exit strategies

Private Equity Wire

The California-based company is collaborating with investment banks Goldman Sachs and Jefferies to explore its alternatives, including the possibility of an initial public offering, the unnamed sources have said, cautioning that these discussions are in the early stages, and no deal is guaranteed.

article thumbnail

Blackstone, Carlyle, and Hellman & Friedman eye $5bn Medline IPO

Private Equity Wire

Medline has reportedly invited multiple investment banks to vie for lead roles in what is expected to be one of the standout IPOs of 2025. In 2021, the company was acquired in a $34bn deal by Blackstone, Carlyle, and Hellman & Friedman. However, plans remain contingent on market conditions.

article thumbnail

Branford Buys Testek from Odyssey

Private Equity Professional

“We are extremely grateful for the support of our previous sponsor, Odyssey Investment Partners, and look forward to continuing to deliver on future growth opportunities with our new partners at Branford Castle.” Testek was advised on the sell-side by Kroll investment banking.